About adsilico
adsilico is a company based in London (United Kingdom) founded in 2022 by Alejandro Frangi, Zeike Taylor, Nishant Ravikumar, and Sheena Macpherson. adsilico has raised $4.56 million across 1 funding round from investors including University of Leeds, Northern Gritstone and Mainspring Fund Services. adsilico offers products and services including In Silico Trials and Virtual Populations. adsilico operates in a competitive market with competitors including Unlearn, ELEM Biotech, Virtonomy, Akkure and Demiurge Technologies, among others.
- Headquarter London, United Kingdom
- Founders Alejandro Frangi, Zeike Taylor, Nishant Ravikumar, Sheena Macpherson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Adsilico Limited
- Date of Incorporation 29 Jul, 2022
- Jurisdiction LEEDS, WEST YORKSHIRE, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.56 M (USD)
in 1 rounds
-
Latest Funding Round
$4.56 M (USD), Seed
Feb 23, 2024
-
Investors
University of Leeds
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of adsilico
adsilico offers a comprehensive portfolio of products and services, including In Silico Trials and Virtual Populations.
Platform for assessing medical device safety using virtual patients.
Generates custom virtual models for diverse patient simulations in research.
People of adsilico
Unlock access to complete
Product Management Team
1 people
Finance and Accounting
1 people
Leadership Team
1 people
Co Team
1 people
Unlock access to complete
Funding Insights of adsilico
adsilico has successfully raised a total of $4.56M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.56 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in adsilico
adsilico has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Leeds, Northern Gritstone and Mainspring Fund Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focused on investing in science and technology firms
|
Locked | Locked | Locked | |
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Locked | Locked | Locked | |
|
Provider of fund administration services
|
Locked | Locked | Locked |
Investor details for adsilico
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by adsilico
Investment portfolio details for adsilico
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - adsilico
Detailed financials for adsilico
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adsilico Comparisons
Peer comparison for adsilico
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of adsilico
adsilico operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unlearn, ELEM Biotech, Virtonomy, Akkure and Demiurge Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based clinical trial management software
|
|
| Locked | Locked | Locked |
A simulation-based platform for virtual medical trials is provided.
|
|
| Locked | Locked | Locked |
Virtual patient simulations are provided for medical device development.
|
|
| Locked | Locked | Locked |
Blockchain-based platform for genomic data analytics is provided.
|
|
| Locked | Locked | Locked |
Developer of neural network models and neuromorphic chips
|
Detailed competitors of adsilico
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adsilico
Complete news archive for adsilico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about adsilico
adsilico was founded in 2022 and raised its 1st funding round 2 years after it was founded.
adsilico is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sheena Macpherson is the current CEO of adsilico. They have also founded this company.
adsilico is a funded company, having raised a total of $4.56M across 1 funding round to date.
Adsilico was founded in 2022 in London, United Kingdom, within the medical technology sector. Computational modeling and simulations are utilized by the company to evaluate device safety and performance in virtual patients. Operations focus on in-silico trials that support medical testing processes, with services centered on virtual assessments to inform regulatory and development decisions.
adsilico's top competitors include Unlearn, Virtonomy and ELEM Biotech.
adsilico offers In Silico Trials and Virtual Populations.
adsilico has 4 investors. Key investors include University of Leeds, Northern Gritstone, Mainspring Fund Services, and Parkwalk.